Moderna Increases Minimum Supply Of Coronavirus Vaccine Doses For 2021
Company Still Anticipates Up To 1 Billion Doses
Executive Summary
The company’s announcement that it would supply at least 600 million doses of mRNA-1273 came as US vaccination rates have fallen far short of expectations.
You may also be interested in...
A Commercial-Stage Moderna Debuts At J.P. Morgan
Moderna has received $2.8bn for advance purchase agreements for its COVID-19 vaccine, with much more to follow. Management outlined some initial financial updates for investors.
Moderna Implements More Expansive Employee COVID-19 Vaccination Program Than Pfizer
Moderna will give its coronavirus vaccine to employees immediately, while Pfizer will wait until workers are eligible under prioritization guidelines.
Coronavirus Update: Moderna Secures Third Approval In Israel, World Leader In COVID-19 Vaccinations
Moderna has just secured its third global authorization for its COVID-19 vaccination in Israel, while the European Medicines Agency's review has been delayed.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports